Product News and Recalls

Woman’s infertility blamed on Yaz

Indiana TV station WTHR recently ran a segment about the birth control pill Yaz, manufactured by Bayer.

The report spotlights Indianapolis-area resident Linda Rosenberg, who is no longer able to conceive children as a result of treatment she received for a blood clot in her ankle. Rosenberg suffered the blood clot after taking Yaz, which numerous studies have linked to blood clots.

WTHR report notes that 50 patients have reportedly died from taking Yaz, Yasmin, and Beyaz, and thousands of others have ...

continue reading...

FDA to study misleading ads such as the 2007-2008 Yaz commercials

The federal Food and Drug Administration will study the impact of “corrective” advertising on consumers’ false perceptions of drug safety and effectiveness.

In a notice posted to the Feb. 29 Federal Register, the agency cited ads run by Bayer in 2009 at FDA’s behest to correct false or misleading claims and omissions it had made when advertising Yaz.

But the agency said: “researchers and policymakers currently lack exhaustive empirical literature regarding the various impacts of corrective (direct-to-consumer) advertisements on prescription drug consumers. ...

continue reading...

Pharmacy mixes up breast cancer drug, children’s fluoride

As many as 50 families may have been affected by a New Jersey CVS Pharmacy’s mixup of children’s fluoride prescriptions, and the breast cancer drug tamoxifen, the Chatham Courier reports.

According to the newspaper, parents who had their children’s fluoride prescriptions filled at the Chatham, N.J., location are between Dec. 20 and Feb. 20 are being asked to check that the pill bottles don’t contain tamoxifen.

The paper quotes a CVS spokesman as saying the company is “deeply sorry for the mistake.”

See ...

continue reading...

Another delay in Yasmin case

For the second time in three months, the U.S. District Court has delayed trial deadlines in the cases over Yaz/Yasmin/Beyaz birth control for 60 days.

Chief Judge David R. Herndon of the Southern District of Illinois announced the delay on Feb. 29. The delay will allow the parties in the case more time to negotiate.

Lopez McHugh is representing multiple plaintiffs against Bayer Healthcare, manufacturer of the birth control pills Yasmin, Yaz, Beyaz, and Ocella. Lopez McHugh’s claim, supported by a ...

continue reading...

Gene therapy promising for Alzheimer’s treatment

A recent study linking Alzheimer’s disease with the repression of gene activity in the brain is a promising development in potential treatment of the disease, according to a recent news release by the National Institutes of Health.

“These findings provide a glimpse of the brain shutting down the ability to form new memories gene by gene in Alzheimer’s disease, and offer hope that we may be able to counteract this process,” said Roderick Corriveau, Ph.D., a program director at NIH’s National ...

continue reading...

Coalition demands more rigorous FDA screening

A coalition of patient, consumer, and public health groups urged the federal Food and Drug Administration to require more rigorous testing before a medical device used for addressing complications from aneurysm treatments can be sold.

“This decision by FDA sets a bad precedent for approving new devices,” said Lisa McGiffert, Director of Consumers Union’s Safe Patient Project. “Medical devices intended to save lives should require the FDA’s most rigorous safety testing. Bypassing such testing up front can put hundreds of thousands ...

continue reading...
Page 311 of 325 «...280290300309310311312313...»